KFI
KRYS icon

Key Financial Inc’s Krystal Biotech KRYS Stock Holding History

Key Financial Inc’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$56.1K Hold
151
– – 0.01% 512
2026
Q1 		$39K Hold
151
– – 0.01% 584
2025
Q4 		$37.2K Hold
151
– – 0.01% 590
2025
Q3 		$27.1K Hold
151
– – 0.01% 649
2025
Q2 		$20.8K Hold
151
– – ﹤0.01% 685
2025
Q1 		$27.2K Hold
151
– – 0.01% 591
2024
Q4 		$23.7K Hold
151
– – 0.01% 618
2024
Q3 		$27.5K Hold
151
– – 0.01% 583
2024
Q2 		$27.7K Buy
+151
New +$25.4K 0.01% 578

Other funds holding KRYS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Key Financial Inc's KRYS Position: Q2 2026 in Review

Key Financial Inc held its Krystal Biotech (KRYS) position steady in Q2 2026 at 151 shares worth $56.1K. The position accounts for 0.01% of the portfolio, ranked #512.

Key Financial Inc first reported a position in KRYS in Q2 2024 and has held it in 9 quarters since. 423 funds tracked by Wall St. Rank hold KRYS as of Q2 2026.

  • Key Financial Inc held 151 shares of Krystal Biotech worth $56.1K as of Q2 2026.
  • Key Financial Inc left its Krystal Biotech share count unchanged in Q2 2026.
  • Krystal Biotech made up 0.01% of Key Financial Inc's portfolio in Q2 2026, its #512 holding.
  • Key Financial Inc first reported a position in Krystal Biotech in Q2 2024 and has held it in 9 quarters since.
  • 423 funds tracked by Wall St. Rank held Krystal Biotech as of Q2 2026.

Based on Key Financial Inc's 13F filing for Q2 2026, filed 24 Jul 2026.